{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:02:19Z","timestamp":1789560139938,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To examine the effect of maternal age on the rate of clinically significant chromosomal microarray analysis results in pregnancies with abnormal maternal serum screening and to establish the residual risk for abnormal microarray findings after omitting noninvasive prenatal testing (NIPT)\u2013detectable aberrations in pregnancies with abnormal maternal serum screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This retrospective study included all chromosomal microarray analysis tests performed in pregnancies with abnormal maternal serum screening and normal ultrasonogram results over the years 2013\u20132021. The rate of clinically significant (pathogenic and likely pathogenic) chromosomal microarray analysis findings was compared with a local control cohort of 7,235 pregnancies with normal maternal serum screening and ultrasonogram results, stratified by maternal age. Calculation of residual risk for clinically significant chromosomal microarray analysis results after normal NIPT was performed by omission of common NIPT-detectable anomalies. Systematic review for studies examining the yield of chromosomal microarray analysis in pregnancies with abnormal maternal serum screening was performed from inception to October 2021, with no time or language restrictions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Of the 559 amniocenteses performed due to abnormal maternal serum screening, 21 (3.8%; 95% CI 2.4\u20135.7%) clinically significant chromosomal microarray analysis results were found. The residual risk for chromosomal microarray analysis aberrations after theoretically normal NIPT was estimated to be 2.0% (95% CI 1.1\u20133.6%) (1\/50) and was significantly higher for women younger than age 35 years with abnormal maternal serum screening, compared with women with low-risk pregnancies. Systematic review yielded six articles encompassing 4,890 chromosomal microarray analysis results in pregnancies with abnormal maternal serum screening, demonstrating 2.3% residual risk for chromosomal microarray analysis anomalies after theoretically normal NIPT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCUSSION:<\/jats:title>\n                    <jats:p>Clinically significant chromosomal microarray analysis findings can be found in 1 of every 50 pregnancies with high-risk maternal serum screening after theoretically normal NIPT, implying that invasive testing and not NIPT should be recommended in such pregnancies. In addition, NIPT use as a first-tier screening modality instead of maternal serum screening would miss pregnancies at increased risk not only for common autosomal trisomies but for additional chromosomal microarray analysis\u2013detectable disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000004758","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T14:04:23Z","timestamp":1652709863000},"page":"877-887","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Chromosomal Microarray Analysis Compared With Noninvasive Prenatal Testing in Pregnancies With Abnormal Maternal Serum Screening"],"prefix":"10.1097","volume":"139","author":[{"given":"Lena","family":"Sagi-Dain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Salzer Sheelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Brabbing-Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reut","family":"Matar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarit","family":"Kahana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifaat","family":"Agmon-Fishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cochava","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merav","family":"Gurevitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Basel-Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idit","family":"Maya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/bmj.297.6653.883","article-title":"Maternal serum screening for Down's syndrome in early pregnancy","volume":"297","author":"Wald","year":"1988","journal-title":"BMJ"},{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1471-0528.1992.tb14474.x","article-title":"Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight","volume":"99","author":"Wald","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/pd.1970151305","article-title":"First trimester serum screening for Down's syndrome","volume":"15","author":"Wald","year":"1995","journal-title":"Prenat Diagn"},{"key":"R4-20260916","first-page":"CD012599","article-title":"First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening","volume":"3","author":"Alldred","year":"2017","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1097\/AOG.0000000000002412","article-title":"Neural tube defects. Practice Bulletin No. 187. American College of Obstetricians and Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3109\/01443615.2014.925857","article-title":"X-linked ichthyosis: differential diagnosis of low maternal oestriol level","volume":"34","author":"Liaugaudiene","year":"2014","journal-title":"J Obstet Gynaecol"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.3109\/14767058.2012.678442","article-title":"Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience","volume":"25","author":"Lau","year":"2012","journal-title":"Journal Maternal-fetal Neonatal Medicine"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/aogs.13047","article-title":"Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis","volume":"96","author":"Iwarsson","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12884-018-2168-4","article-title":"Facilitating informed choice about non-invasive prenatal testing (NIPT): a systematic review and qualitative meta-synthesis of women's experiences","volume":"19","author":"Cernat","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1038\/s41436-019-0550-x","article-title":"Chromosomal microarray vs. NIPS: analysis of 5541 low-risk pregnancies","volume":"21","author":"Sagi-Dain","year":"2019","journal-title":"Genet Med"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/uog.17548","article-title":"Chromosomal microarray as primary diagnostic genomic tool for pregnancies at increased risk within a population-based combined first-trimester screening program","volume":"51","author":"Vogel","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"287.e1","DOI":"10.1016\/j.ajog.2018.05.030","article-title":"Prospective chromosome analysis of 3429 amniocentesis samples in China using copy number variation sequencing","volume":"219","author":"Wang","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R14-20260916","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/gim.2017.89","article-title":"When genotype is not predictive of phenotype: implications for genetic counseling based on 21,594 chromosomal microarray analysis examinations","volume":"20","author":"Maya","year":"2018","journal-title":"Genet Med"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41436-019-0686-8","article-title":"Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)","volume":"22","author":"Riggs","year":"2020","journal-title":"Genet Med"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/gim.2012.164","article-title":"Estimates of penetrance for recurrent pathogenic copy-number variations","volume":"15","author":"Rosenfeld","year":"2013","journal-title":"Genet Med"},{"key":"R18-20260916","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF00276595","article-title":"Rates of trisomies 21, 18, 13 and other chromosome abnormalities in about 20 000 prenatal studies compared with estimated rates in live births","volume":"61","author":"Schreinemachers","year":"1982","journal-title":"Hum Genet"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1001\/jama.1983.03330390038028","article-title":"Chromosomal abnormality rates at amniocentesis and in live-born infants","volume":"249","author":"Hook","year":"1983","journal-title":"JAMA"},{"key":"R20-20260916","article-title":"Residual risk for clinically significant copy number variants in low-risk pregnancies, following exclusion of noninvasive prenatal screening-detectable findings","author":"Maya","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/pd.5223","article-title":"Predicting fetoplacental chromosomal mosaicism during non-invasive prenatal testing","volume":"38","author":"Brison","year":"2018","journal-title":"Prenat Diagn"},{"key":"R22-20260916","doi-asserted-by":"crossref","first-page":"624","DOI":"10.25122\/jml-2020-0092","article-title":"Cytogenetics and molecular investigations detect a mosaic variant of turner syndrome only suspected by non-invasive prenatal testing: two case reports with negative ultrasound examinations","volume":"13","author":"Libotte","year":"2020","journal-title":"J Med Life"},{"key":"R23-20260916","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tjog.2017.09.001","article-title":"Application of non-invasive prenatal testing in late gestation in a pregnancy associated with intrauterine growth restriction and trisomy 22 confined placental mosaicism","volume":"56","author":"Chen","year":"2017","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R24-20260916","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1038\/s41436-019-0564-4","article-title":"Maternal copy-number variations in the DMD gene as secondary findings in noninvasive prenatal screening","volume":"21","author":"Brison","year":"2019","journal-title":"Genet Med"},{"key":"R25-20260916","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"R26-20260916","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1056\/NEJMoa1203382","article-title":"Chromosomal microarray versus karyotyping for prenatal diagnosis","volume":"367","author":"Wapner","year":"2012","journal-title":"N Engl J Med"},{"key":"R27-20260916","doi-asserted-by":"crossref","first-page":"571219","DOI":"10.3389\/fgene.2020.571219","article-title":"Clinical utility of SNP array analysis in prenatal diagnosis: a cohort study of 5000 pregnancies","volume":"11","author":"Xiang","year":"2020","journal-title":"Front Genet"},{"key":"R28-20260916","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1111\/jcmm.16589","article-title":"Chromosomal microarray analysis for pregnancies with abnormal maternal serum screening who undergo invasive prenatal testing","volume":"25","author":"Wu","year":"2021","journal-title":"J Cell Mol Med"},{"key":"R29-20260916","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2147\/IJWH.S324529","article-title":"Prenatal diagnostic testing following high-risk result from serological screening: which shall we select?","volume":"13","author":"Wang","year":"2021","journal-title":"Int J Womens Health"},{"key":"R30-20260916","first-page":"1043","article-title":"Age related detection and false positive rates when screening for Down's syndrome in the first trimester using fetal nuchal translucency and maternal serum free betahCG and PAPP-A","volume":"108","author":"Spencer","year":"2001","journal-title":"BJOG"},{"key":"R31-20260916","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/096914139700400402","article-title":"Antenatal screening for Down's syndrome","volume":"4","author":"Wald","year":"1997","journal-title":"J Med Screen"},{"key":"R32-20260916","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/pd.1970120309","article-title":"The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study","volume":"12","author":"Marteau","year":"1992","journal-title":"Prenatal Diagn"},{"key":"R33-20260916","doi-asserted-by":"crossref","first-page":"iii, ix-x, 1","DOI":"10.3310\/hta8330","article-title":"Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review","volume":"8","author":"Green","year":"2004","journal-title":"Health Technol Assess"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004758","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:04:12Z","timestamp":1789556652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004758","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,5]]},"assertion":[{"value":"2021-11-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}